In particular, it has been found that heterozygous mutations in CD95 causing the autoimmune lymphoproliferative syndrome (ALPS) interfere with CD95L binding in a dominant-negative fashion, too (Siegel et al., 2000). This evidence concerns the gene FAS and autoimmune lymphoproliferative syndrome.